InvestorsHub Logo
Followers 18
Posts 908
Boards Moderated 0
Alias Born 09/28/2014

Re: longfellow95 post# 208472

Tuesday, 01/15/2019 3:06:03 PM

Tuesday, January 15, 2019 3:06:03 PM

Post# of 711950

“Truthfan, any idea if this is the same offering they put out a while back, or just a repeat offer of the same thing, or something new?

Some interesting bits tucked away like the technology share between InMune and Novacure, with Inmune focussing on in vivo priming and Novacure on ex-vivo
And the amount of time that Mark Lowdell is contracted to devote to InMune.

And I'm sure lots more for someone with more thorough DD than me to turn up.”




LF95
Just started to look at this company - $8 for common share is the same number I’ve seen previously. Admittedly, I didn’t peruse their filings.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News